AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
Na minha lista:
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Livro |
| Idioma: | inglês |
| Publicado em: |
Dhaka :
BME DEPT. MIST,
c2026.
|
| Assuntos: | |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados: AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
- IDENTIFICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH
- IDENTICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH /
- Inside the FDA : the business and politics behind the drugs we take and the food we eat /
- AN INTEGRATED TRANSCRIPTOMIC APPROACH TO IMMUNE PROFILING, HUB GENE DETECTION, AND IDENTIFICATION OF REPURPOSABLE DRUGS IN PANCREATIC CANCER /
- AN IN-SILICO APPROACH TO COMPARE MUTANT E PROTEIN STRUCTURE BETWEEN OLD AND RECENT DENGUE VIRUS EPISODES /
- ART AGAINST GENOCIDE /